We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Molecular Diagnostics

Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

New findings highlight the role of MRD detection in breast cancer management, showing that ctDNA monitoring can predict progression up to years earlier. More...
27 May 2026
Image: MCD tests are designed to detect multiple cancers from a single blood sample, but the statements note that evaluating these assays is far more complex than assessing single-cancer tests (image credit: Adobe Stock)

Position Statements Outline Evidence Standards for Multi-Cancer Detection Tests

New position statements outline evidence standards for assessing emerging multi-cancer detection tests. More...
27 May 2026
Image: Physicians currently use the Demicco score, which considers patient age, tumor size, and microscopic appearance, to estimate SFT aggressiveness, but uncertainty can remain about which patients need closer surveillance (image credit: Shutterstock)

Gene Fusion Patterns May Flag High Risk Solitary Fibrous Tumors

Specific genetic fusion patterns may add precision by helping identify SFTs more likely to recur or spread. More...
26 May 2026
Image: The study represents a major pediatric oncology breakthrough, offering a potential roadmap for personalizing treatment in difficult-to-treat childhood cancers (image credit: Adobe Stock)

Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers

A measure of tumor chromosome abnormalities predicts benefit from irinotecan plus a PARP inhibitor in relapsed pediatric cancers. More...
25 May 2026
Image: The new RNA origami method achieved 18-nucleotide resolution, enough to distinguish healthy from disease-associated repeat sections (image credit: Adobe Stock)

New RNA Origami Method Supports Faster Targeted Testing for Repeat Expansion Disorders

An RNA 'origami' nanopore method distinguishes disease‑associated repeat lengths using minimal RNA. More...
23 May 2026
Image: The new Guardant360 Liquid CDx assay measures a 100‑fold wider genomic footprint than the previously approved Guardant360 CDx (Photo courtesy of Guardant Health)

FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling

Guardant360 Liquid CDx is the largest FDA-approved liquid biopsy panel, assessing a 100-fold wider genomic footprint than the previous Guardant360 CDx. More...
21 May 2026
Image: The approach profiles bacteria in saliva and applies machine-learning algorithms to distinguish patients with ESCC from unaffected controls (image credit: Adobe Stock)

Microbial Saliva Test Could Help Triage Esophageal Cancer Risk

An AI approach using saliva microbiome profiles flags esophageal squamous cell carcinoma, outperforming clinical variables. More...
21 May 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Chromogenic Culture System
InTray™ COLOREX™ ECC


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.